The rating is based on a number of factors, including TMC’s unique role in coordinating capital investment, initiatives and services on a large medical complex.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that TMC will continue to generate strong cash flow even as it funds the formation of five research institutes.
More articles on healthcare finance:
For-profit hospital stock report: Week of Sept. 12-16
15 healthcare CFOs in the headlines
Henry Ford closes on $1B bond sale
